Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth+0.54%

4
27.69%
1 Year Return
Equity
Sectoral-Pharma
4.0star
6M
1Y
All

Fund Details

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

RiskHigh
Min SIP Amount₹500
Expense Ratio0.92%
NAV12.94 (13 Jul 2020)
Fund Started10 Jul 2019
Fund Size264 Cr

Returns

1Y
3Y*
5Y*
Since inception*
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
27.7%
NA
NA
29.0%
Category Average
34.5%
9.3%
4.7%
-
Rank within category
NA
NA
NA
-
*All returns are annualized.
SIP
Lumpsum
I want to invest per month5,000
    Estimated Value
    as per Historical Returns
    0
    with 27.7% annual returns

    Comparison

    Data not available
    Pros
    Found nothing so far.
    Cons
    Found nothing so far.

    Top Holdings

    NameSectorInstrument% Assets
    Cipla Ltd.HealthcareEquity10.6%
    Dr. Reddy's Laboratories Ltd.HealthcareEquity9.6%
    Sun Pharmaceutical Inds. Ltd.HealthcareEquity9.2%
    Divi's Laboratories Ltd.HealthcareEquity6.9%
    Lupin Ltd.HealthcareEquity5.1%
    Atul Ltd.ChemicalsEquity4.9%
    Zydus Wellness Ltd.FMCGEquity4.7%
    Cadila Healthcare Ltd.HealthcareEquity4.6%
    Biocon Ltd.HealthcareEquity4.3%
    Apollo Hospitals Enterprise Ltd.HealthcareEquity3.9%
    See All

    Fund Managers

    addDhaval Shah

    Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Details

    Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Aditya Birla Sun Life Mutual Fund. This scheme was made available to investors on 10 Jul 2019. Dhaval Shah is the Current Fund Manager of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹264 Cr and the Latest NAV as of 13 Jul 2020 is ₹12.94.

    The Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is rated High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 1000. Exit load of 0.5% if redeemed within 90 days.

    Investment Objective

    The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.

    Scheme Information Document(SID)

    ₹1000
    Min for First Investment
    ₹1000
    Min for Second Investment
    Exit load of 0.5% if redeemed within 90 days.
    Exit Load

    Compare Funds

    Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
    VS
    search

    About Aditya Birla Sun Life Mutual Fund

    Address
    One India Bulls Centre ,Tower 1, 17th Flr, Jupiter Mill Compound,841,S.B. Marg,Elphinstone Road Mumbai 400 013
    Phone
    022 43568000
    Launch Date
    23 Dec 1994
    Aditya Birla Sun Life Mutual Fund
    Asset Management Company
    Custodian
    Citibank NA
    Registrar & Transfer Agent
    Cams
    Address
    7th Floor, Tower II, Rayala Towers, 158, Anna Salai,
    Similar Funds
    Data not available